Home
Our Journey
About Us
Social Impact
About Damon Quisenberry
About AI System
Market Analysis
Investment Learning
American Equities
Capital Funds
Bond Securities
Currency Markets
Virtual Currencies
Worldwide Economics
Portfolio Strategies
Compliance Policies
Wealth Building
DZA Token
Strategy and Vision
Weekly Handpicked Stock Collection
Digital Learning
Learning archive
Online Event
Online Raffles
Voting Campaigns
Learning archive
Sangamo Therapeutics Stock Slumps After Pfizer Terminates Hemophilia A Gene Therapy Partnership
December 31, 2024
Sangamo Therapeutics' (SGMO) shares were sinking intraday Tuesday after the company said its partner